AIP
FHTX icon

Ameritas Investment Partners’s Foghorn Therapeutics FHTX Stock Holding History

Ameritas Investment Partners’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16K Hold
3,343
– – ﹤0.01% 2692
2025
Q4 		$18.1K Hold
3,343
– – ﹤0.01% 2679
2025
Q3 		$16.3K Hold
3,343
– – ﹤0.01% 2757
2025
Q2 		$15.7K Buy
3,343
+1,809
+118% +$7.56K ﹤0.01% 2765
2025
Q1 		$5.6K Hold
1,534
– – ﹤0.01% 2949
2024
Q4 		$7.24K Hold
1,534
– – ﹤0.01% 2981
2024
Q3 		$14.3K Hold
1,534
– – ﹤0.01% 2800
2024
Q2 		$8.82K Hold
1,534
– – ﹤0.01% 2963
2024
Q1 		$10.3K Hold
1,534
– – ﹤0.01% 2806
2023
Q4 		$9.89K Hold
1,534
– – ﹤0.01% 2845
2023
Q3 		$7.67K Hold
1,534
– – ﹤0.01% 2904
2023
Q2 		$10.8K Hold
1,534
– – ﹤0.01% 2880
2023
Q1 		$9.51K Hold
1,534
– – ﹤0.01% 2741
2022
Q4 		$12.4K Hold
1,534
– – ﹤0.01% 2747
2022
Q3 		$13K Hold
1,534
– – ﹤0.01% 2706
2022
Q2 		$20K Hold
1,534
– – ﹤0.01% 2538
2022
Q1 		$23K Hold
1,534
– – ﹤0.01% 2492
2021
Q4 		$35K Hold
1,534
– – ﹤0.01% 2345
2021
Q3 		$21K Hold
1,534
– – ﹤0.01% 2663
2021
Q2 		$16K Buy
1,534
+932
+155% +$10.2K ﹤0.01% 2833
2021
Q1 		$8K Hold
602
– – ﹤0.01% 2917
2020
Q4 		$12K Buy
+602
New +$11.5K ﹤0.01% 2706

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Ameritas Investment Partners's FHTX Position: Q1 2026 in Review

Ameritas Investment Partners held its Foghorn Therapeutics (FHTX) position steady in Q1 2026 at 3,343 shares worth $16K. The position accounts for ﹤0.01% of the portfolio, ranked #2692.

Ameritas Investment Partners first reported a position in FHTX in Q4 2020 and has held it in 22 quarters since. The position peaked at $35K in Q4 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Ameritas Investment Partners held 3,343 shares of Foghorn Therapeutics worth $16K as of Q1 2026.
  • Ameritas Investment Partners left its Foghorn Therapeutics share count unchanged in Q1 2026.
  • Foghorn Therapeutics made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2692 holding.
  • Ameritas Investment Partners first reported a position in Foghorn Therapeutics in Q4 2020 and has held it in 22 quarters since.
  • Ameritas Investment Partners's Foghorn Therapeutics position peaked at $35K in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.